p53 is important for the anti-proliferative effect of ibuprofen in colon carcinoma cells

Biochemical and Biophysical Research Communications

Volumn 365, Issue 4, 2008, Pages 698-703

  Janssen, Astrid ^a   Schiffmann, Susanne ^a   Birod, Kerstin ^a   Maier, Thorsten J ^a   Wobst, Ivonne ^a   Geisslinger, Gerd ^a   Grösch, Sabine ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Anti proliferative; Bax; Ibuprofen; p53; p75NTR

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IBUPROFEN; NEUROTROPHIN RECEPTOR P75; PROTEIN BAX; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; XENOGRAFT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IBUPROFEN; NERVE TISSUE PROTEINS; RECEPTORS, NERVE GROWTH FACTOR; TUMOR SUPPRESSOR PROTEIN P53;

MUS MUSCULUS;

EID: 36849013175     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.051     Document Type: Article

References (22)

1. Thun M.J., Namboodiri M.M., and Heath Jr. C.W. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325 (1991) 1593-1596
2. Ginsburg A.P., Cheetham J.K., DeGryse R.E., and Abelson M. Effects of flurbiprofen and indomethacin on acute cystoid macular edema after cataract surgery: functional vision and contrast sensitivity. J. Cataract Refract. Surg. 21 (1995) 82-92
3. Peleg I., Lubin M.F., Cotsonis G.A., Clark W.S., and Wilcox C.M. Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia. Dig. Dis. Sci. 41 (1996) 1319-1326
4. Reddy B.S., Tokumo K., Kulkarni N., Aligia C., and Kelloff G. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis 13 (1992) 1019-1023
5. Andrews J., Djakiew D., Krygier S., and Andrews P. Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells. Cancer Chemother. Pharmacol. 50 (2002) 277-284
6. Araki Y., Okamura S., Hussain S.P., Nagashima M., He P., Shiseki M., Miura K., and Harris C.C. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res. 63 (2003) 728-734
7. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adeno carcinomas. Gastroenterology 107 (1994) 1183-1188
8. Kargman S.L., O'Neill G.P., Vickers P.J., Evans J.F., Mancini J.A., and Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55 (1995) 2556-2559
9. Piazza G.A., Rahm A.L., Krutzsch M., Sperl G., Paranka N.S., Gross P.H., Brendel K., Burt R.W., Alberts D.S., Pamukcu R., et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55 (1995) 3110-3116
10. Grosch S., Tegeder I., Schilling K., Maier T.J., Niederberger E., and Geisslinger G. Activation of c-Jun-N-terminal-kinase is crucial for the induction of a cell cycle arrest in human colon carcinoma cells caused by flurbiprofen enantiomers. FASEB J. 17 (2003) 1316-1318
11. Neupert W., Brugger R., Euchenhofer C., Brune K., and Geisslinger G. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. Br. J. Pharmacol. 122 (1997) 487-492
12. Janssen A., Maier T.J., Schiffmann S., Coste O., Seegel M., Geisslinger G., and Grosch S. Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment. Eur. J. Pharmacol. 540 (2006) 24-33
13. Sionov R.V., and Haupt Y. The cellular response to p53: the decision between life and death. Oncogene 18 (1999) 6145-6157
14. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., and Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282 (1998) 1497-1501
15. Maier T.J., Janssen A., Schmidt R., Geisslinger G., and Grosch S. Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. FASEB J. 19 (2005) 1353-1355
16. NTR tumour suppressor protein. Cancer Res. 64 (2004) 6207-6213
17. Aloyz R.S., Bamji S.X., Pozniak C.D., Toma J.G., Atwal J., Kaplan D.R., and Miller F.D. p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J. Cell. Biol. 143 (1998) 1691-1703
18. Jin H., Pan Y., Zhao L., Zhai H., Li X., Sun L., He L., Chen Y., Hong L., Du Y., and Fan D. p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells. Neoplasia 9 (2007) 471-478
19. NTR-dependent decreased survival of prostate tumour cells. Cancer Res. 67 (2007) 3254-3262
20. Liepinsh E., Ilag L.L., Otting G., and Ibanez C.F. NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J. 16 (1997) 4999-5005
21. Kaplan D.R., and Miller F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10 (2000) 381-391
22. Tabassum A., Khwaja F., and Djakiew D. The p75(NTR) tumour suppressor induces caspase-mediated apoptosis in bladder tumour cells. Int. J. Cancer 105 (2003) 47-52